Literature DB >> 33275949

Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.

.   

Abstract

BACKGROUND: Many causes of vision impairment can be prevented or treated. With an ageing global population, the demands for eye health services are increasing. We estimated the prevalence and relative contribution of avoidable causes of blindness and vision impairment globally from 1990 to 2020. We aimed to compare the results with the World Health Assembly Global Action Plan (WHA GAP) target of a 25% global reduction from 2010 to 2019 in avoidable vision impairment, defined as cataract and undercorrected refractive error.
METHODS: We did a systematic review and meta-analysis of population-based surveys of eye disease from January, 1980, to October, 2018. We fitted hierarchical models to estimate prevalence (with 95% uncertainty intervals [UIs]) of moderate and severe vision impairment (MSVI; presenting visual acuity from <6/18 to 3/60) and blindness (<3/60 or less than 10° visual field around central fixation) by cause, age, region, and year. Because of data sparsity at younger ages, our analysis focused on adults aged 50 years and older.
FINDINGS: Global crude prevalence of avoidable vision impairment and blindness in adults aged 50 years and older did not change between 2010 and 2019 (percentage change -0·2% [95% UI -1·5 to 1·0]; 2019 prevalence 9·58 cases per 1000 people [95% IU 8·51 to 10·8], 2010 prevalence 96·0 cases per 1000 people [86·0 to 107·0]). Age-standardised prevalence of avoidable blindness decreased by -15·4% [-16·8 to -14·3], while avoidable MSVI showed no change (0·5% [-0·8 to 1·6]). However, the number of cases increased for both avoidable blindness (10·8% [8·9 to 12·4]) and MSVI (31·5% [30·0 to 33·1]). The leading global causes of blindness in those aged 50 years and older in 2020 were cataract (15·2 million cases [9% IU 12·7-18·0]), followed by glaucoma (3·6 million cases [2·8-4·4]), undercorrected refractive error (2·3 million cases [1·8-2·8]), age-related macular degeneration (1·8 million cases [1·3-2·4]), and diabetic retinopathy (0·86 million cases [0·59-1·23]). Leading causes of MSVI were undercorrected refractive error (86·1 million cases [74·2-101·0]) and cataract (78·8 million cases [67·2-91·4]).
INTERPRETATION: Results suggest eye care services contributed to the observed reduction of age-standardised rates of avoidable blindness but not of MSVI, and that the target in an ageing global population was not reached. FUNDING: Brien Holden Vision Institute, Fondation Théa, The Fred Hollows Foundation, Bill & Melinda Gates Foundation, Lions Clubs International Foundation, Sightsavers International, and University of Heidelberg.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Year:  2020        PMID: 33275949     DOI: 10.1016/S2214-109X(20)30489-7

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  221 in total

1.  Lipid dismantling of lens organelles for clear vision.

Authors:  Patricia Boya
Journal:  Nature       Date:  2021-04       Impact factor: 49.962

2.  Relation of Maximum Lifetime Body Mass Index with Age at Hemodialysis Initiation and Vascular Complications in Japan.

Authors:  Akira Onozaki; Daiji Nagayama; Nakanobu Azuma; Keita Sugai; Etsuko Shitara; Takehiko Sakai; Motoyuki Masai; Kohji Shirai; Ichiro Tatsuno
Journal:  Obes Facts       Date:  2021-08-13       Impact factor: 3.942

3.  Image enhancement of color fundus photographs for age-related macular degeneration: the Shanghai Changfeng Study.

Authors:  Jing-Jing Shen; Rui Wang; Li-Long Wang; Chuan-Feng Lyu; Shuo Liu; Guo-Tong Xie; Hai-Luan Zeng; Ling-Yan Chen; Min-Qian Shen; Xin Gao; Huan-Dong Lin; Yuan-Zhi Yuan
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

4.  Novel Role of Prereplication Complex Component Cell Division Cycle 6 in Retinal Neovascularization.

Authors:  Raj Kumar; Gadiparthi N Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-03-03       Impact factor: 8.311

5.  The association between cataract and sleep apnea: a nationwide population-based cohort study.

Authors:  Pei-Kang Liu; Yo-Chen Chang; Nan-Kai Wang; Joseph Ryu; Rong-Kung Tsai; Shiuh-Liang Hsu; Jen-Yu Hung; Chung-Yao Hsu; Ming-Hong Tai; Ming-Ju Tsai
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

6.  The Association of Cognitive and Visual Function in a Nationally Representative Study of Older Adults in India.

Authors:  Joshua R Ehrlich; Tochukwu Ndukwe; Sandy Chien; Jinkook Lee
Journal:  Neuroepidemiology       Date:  2021-02-24       Impact factor: 3.282

Review 7.  Oxidative and Nitrosative Stress in Age-Related Macular Degeneration: A Review of Their Role in Different Stages of Disease.

Authors:  Caterina Toma; Stefano De Cillà; Aurelio Palumbo; Divya Praveen Garhwal; Elena Grossini
Journal:  Antioxidants (Basel)       Date:  2021-04-23

8.  Blood Pressure and Glaucomatous Progression in a Large Clinical Population.

Authors:  Alessandro A Jammal; Samuel I Berchuck; Eduardo B Mariottoni; Angelo P Tanna; Vital P Costa; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2021-08-30       Impact factor: 12.079

9.  Frugal retinal laser training simulation eyes.

Authors:  Obaid Kousha; Blazej Staniszewski; Juan Lopez Ulloa; Sonali Tarafdar; John Ellis; Andrew Blaikie
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 4.456

Review 10.  Searching for the Antioxidant, Anti-Inflammatory, and Neuroprotective Potential of Natural Food and Nutritional Supplements for Ocular Health in the Mediterranean Population.

Authors:  Mar Valero-Vello; Cristina Peris-Martínez; José J García-Medina; Silvia M Sanz-González; Ana I Ramírez; José A Fernández-Albarral; David Galarreta-Mira; Vicente Zanón-Moreno; Ricardo P Casaroli-Marano; María D Pinazo-Duran
Journal:  Foods       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.